Nantes University Hospital
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1503-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.chu-nantes.fr
A Transversal Study for the French Validation of Two Assessment Tools of Gambling Related Cognitions.
Completed
- Conditions
- Gambling
- Interventions
- Other: Filling of three questionnaires
- First Posted Date
- 2010-10-13
- Last Posted Date
- 2011-05-20
- Lead Sponsor
- Nantes University Hospital
- Registration Number
- NCT01219426
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, France
Therapeutic Innovation in Type 2 DIABetes (IT-DIAB)
Not Applicable
- Conditions
- Pre-diabetes
- First Posted Date
- 2010-10-11
- Last Posted Date
- 2017-06-16
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 366
- Registration Number
- NCT01218061
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, France
Transversal Multiaxial Evaluation and 5-year Follow-up of a Cohort of French Gamblers (JEU)
Not Applicable
Completed
- Conditions
- Pathological or "at Risk" Gambling
- First Posted Date
- 2010-09-23
- Last Posted Date
- 2018-02-15
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 641
- Registration Number
- NCT01207674
- Locations
- 🇫🇷
Clermont Ferrand university Hospital, Clermont Ferrand, France
🇫🇷Bordeaux University Hospital, Bordeaux, France
🇫🇷Louis Mourier hospital, Colombes, France
Involvement of Transverso-sacral- Neo- Articulations or of Transverso-iliac Articulations in Chronic Lumbago
Phase 4
Terminated
- Conditions
- Subjects Suffering of Lateralized Lumbago on Side of the Malformation (Neo-articulation)
- Interventions
- Drug: corticoid (altim® 1.5 ml)Drug: physiological solution (1.5 ml)
- First Posted Date
- 2010-09-22
- Last Posted Date
- 2015-11-03
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT01206699
- Locations
- 🇫🇷
Hospital of La Roche/Yon, La Roche/Yon, France
🇫🇷Nantes Hospital, Nantes, France
Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease
Not Applicable
Completed
- Conditions
- Patients With Gaucher's Disease
- First Posted Date
- 2010-09-22
- Last Posted Date
- 2011-12-02
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT01206673
- Locations
- 🇫🇷
CHU of Rennes, Rennes, France
🇫🇷Nantes Hospital, Nantes, France
Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure
- First Posted Date
- 2010-08-25
- Last Posted Date
- 2014-12-05
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT01188174
- Locations
- 🇫🇷
Nantes University hospital, Nantes, France
🇫🇷CHU Caen, Caen, France
🇫🇷CHRU lille, Lille, France
Contribution of Salivary Cortisol in the Detection of Infra-clinic Cortisol Adenoma (ACIC)
Not Applicable
Terminated
- Conditions
- Obesity
- Interventions
- Other: Salivary Cortisol
- First Posted Date
- 2010-07-05
- Last Posted Date
- 2014-07-22
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 514
- Registration Number
- NCT01156519
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, France
ORN Study: Curative Treatment of Osteoradionecrosis (ORN) With Hybrid Bone Substitution
Not Applicable
Completed
- Conditions
- MandibleOsteoradionecrosis
- Interventions
- Procedure: Hybrid bone substitution
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2018-04-06
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 13
- Registration Number
- NCT01147315
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, France
🇫🇷Rennes University Hospital, Rennes, France
Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM)
Phase 1
- Conditions
- Acute Myelogenous Leukemia
- First Posted Date
- 2010-06-17
- Last Posted Date
- 2016-07-26
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT01146262
- Locations
- 🇫🇷
Cellule de Promotion de la recherche clinique, Nantes, France
Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)
Phase 2
Completed
- Conditions
- Graft Versus Host Disease
- Interventions
- First Posted Date
- 2010-06-03
- Last Posted Date
- 2014-04-03
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT01135641
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, France
© Copyright 2025. All Rights Reserved by MedPath